[Physio-pathological bases of the symptomatic treatment of asthma].
D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001285:Atropine / Q000627:therapeutic use; D001980:Bronchi / Q000187:drug effects* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D000242:Cyclic AMP / Q000097:blood; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011458:Prostaglandins E / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013566:Sympathomimetics / Q000627:therapeutic use; D014630:Vagus Nerve / Q000187:drug effects; D014970:Xanthines / Q000627:therapeutic use
D001993:Bronchodilator Agents; D005938:Glucocorticoids; D011458:Prostaglandins E; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D014970:Xanthines; D001285:Atropine; D000242:Cyclic AMP; D004205:Cromolyn Sodium
Bases physio-pathologiques du traitement symptomatique de l'asthme.